A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: heave (2), gag (20)

Regorafenib

Description
Chemotherapy Protocol Gastro-Intestinal Stromal Tumour Regorafenib Regimen • GIST – Regorafenib Indication • Regorafenib is recommended for histologically confirmed metastatic or unresectable gastronintestinal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Regorafenib.pdf

Regorafenib

Description
Chemotherapy Protocol Hepatocellular Cancer Regorafenib Regimen • Hepatocellular – Regorafenib Indication • Regorafenib is recommended as an option for treating advanced unresectable hepatocellular carcinoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Regorafenib.pdf

ImatinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the preferred first-line treatment for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf

ImatinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication • As the preferred option for the treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf

DasatinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications Regimen • CML – Dasatinib (chronic phase) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf

DasatinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (accelerated phase) Funding may be required for specific indications Regimen • CML – Dasatinib (accelerated phase) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibAccelerated.pdf

Bosutinib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Bosutinib Regimen • Bosutinib Indication • As an option for the treatment of patients with chronic phase, accelerated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Bosutinib.pdf

Taking oral systemic anti-cancer therapy (SACT) - patient information

Description
This factsheet gives information about taking oral systemic anti-cancer therapy (SACT).
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Taking-oral-systemic-anti-cancer-therapy-SACT-3103-PIL.pdf

Steroid therapy for brain tumours - patient information

Description
Information about steroid therapy for brain tumours.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Steroid-therapy-for-brain-tumours-494-PIL.pdf

Letrozole-Palbociclib

Description
Chemotherapy Protocol Breast Cancer Letrozole-Palbociclib Regimen • Breast Cancer – Letrozole-Palbociclib Indication • Palbociclib in combination with an aromatase inhibitor is indicated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Letrozole-Palbociclib.pdf
211 to 220 of 344
Previous … 20 21 22 23 24 … Next